3rd Dose of COVID-19 Vaccine Authorized for Immunocompromised in US
Uncategorizedđź’ĄBREAKINGđź’Ą: 3rd dose COVID-19 vaccine authorization & recommendation for immunocompromised in the U.S. Yesterday (August 12th,) the U.S. Food and Drug Administration (FDA) authorized an additional dose of the Pfizer and Moderna vaccines for certain immunocompromised individuals ages 12+. Today (August 13th) the CDC’s Advisory Committee on Immunization Practices (ACIP) also voted to recommend these Read more…